Icon (ICLR) Amortization of Deferred Charges (2016 - 2026)
Icon's (ICLR) quarterly Amortization of Deferred Charges came in at $1.5 million in Q2 2026, up 2.55% year-over-year from $1.5 million in Q2 2025, and up 0.66% quarter-over-quarter from $1.5 million in Q1 2026.
Analysis
Icon (ICLR) Amortization of Deferred Charges (2016 - 2026) Analysis & Trends
Icon (ICLR) has reported Amortization of Deferred Charges for 11 consecutive years, with $1.5 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Amortization of Deferred Charges rose 2.55% year-over-year to $1.5 million in Q2 2026; TTM through Jun 2026 was $203.8 million, a 9.44% decrease from a year earlier, with the FY2025 full-year figure at $203.7 million, down 16.05% from the prior year.
- Amortization of Deferred Charges was $1.5 million for Q2 2026 at Icon, up from $1.5 million in the prior quarter.
- Over five years, Amortization of Deferred Charges peaked at $220.6 million in Q4 2024 and troughed at $1.5 million in Q3 2024.
- A 5-year average of $26.9 million and a median of $3.9 million in 2023 frame the typical range for Amortization of Deferred Charges.
- Across the five-year window, Amortization of Deferred Charges surged 5530.58% in 2024 and tumbled 91.07% in 2025, its largest moves.
- Over 5 years, Amortization of Deferred Charges stood at $4.2 million in 2022, then retreated by 6.85% to $3.9 million in 2023, then surged by 5530.58% to $220.6 million in 2024, then fell by 9.68% to $199.2 million in 2025, then slumped by 99.23% to $1.5 million in 2026.
- The last three Amortization of Deferred Charges figures came in at $1.5 million (Q2 2026), $1.5 million (Q1 2026), and $199.2 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.53 Mn |
| Mar 31, 2026 | 1.52 Mn |
| Dec 31, 2025 | 199.20 Mn |
| Sep 30, 2025 | 1.50 Mn |
| Jun 30, 2025 | 1.49 Mn |
| Mar 31, 2025 | 1.48 Mn |
| Dec 31, 2024 | 220.55 Mn |
| Sep 30, 2024 | 1.46 Mn |
| Jun 30, 2024 | 16.70 Mn |
| Mar 31, 2024 | 3.91 Mn |
| Dec 31, 2023 | 3.92 Mn |
| Sep 30, 2023 | 4.59 Mn |
| Jun 30, 2023 | 3.40 Mn |
| Mar 31, 2023 | 4.50 Mn |
| Dec 31, 2022 | 4.21 Mn |
| Sep 30, 2022 | 4.36 Mn |
| Jun 30, 2022 | 3.41 Mn |
| Mar 31, 2022 | 5.78 Mn |
| Dec 31, 2021 | 8.44 Mn |
| Sep 30, 2021 | 2.86 Mn |